Cost-effectiveness of a cervical screening program with human papillomavirus vaccine

Elizaveta (Liza) Sopina*, Toni Ashton

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Objectives: Recent introduction of a quadrivalent human papillomavirus (HPV) vaccine for girls in New Zealand is expected to decrease the incidence of HPV infection as well as resultant cytological abnormalities and cervical cancer. This may affect the cost-effectiveness of the national cervical screening program by reducing the incidence of lesions detected. This study investigates the cost-effectiveness of the current cervical screening policy with and without the HPV vaccine and compares these results with the cost-effectiveness of a range of other screening strategies. Methods: A Markov state-transition model was built based on the natural history of HPV and cervical carcinogenesis. The model followed a hypothetical cohort of girls from 12 years to 85 years of age or death, through screening and treatment pathways. The model compared a "no vaccine and current screening" strategy with a selection of screening strategies with different age ranges and frequency intervals. Results: The most cost-effective cervical screening strategy in the presence of the HPV vaccine would be screening women aged 30-60 every 5 years. Moving to this screening strategy from the base case of no vaccine and the current New Zealand strategy of screening women aged 20-69 every 3 years is predicted to have an incremental cost per quality-adjusted life-year gained of NZ$9,841 (€4,428). Conclusions: Reducing screening intensity from 3 to 5 years as well as narrowing the screening age range for the vaccinated cohort once they reach mid-twenties is recommended. The importance of achieving a high vaccine uptake in New Zealand remains high.

Original languageEnglish
JournalInternational Journal of Technology Assessment in Health Care
Volume27
Issue number4
Pages (from-to)290-297
ISSN0266-4623
DOIs
Publication statusPublished - 1. Oct 2011
Externally publishedYes

Keywords

  • Cervical cancer
  • Cervical screening
  • Cost-effectiveness
  • HPV vaccine

Fingerprint

Dive into the research topics of 'Cost-effectiveness of a cervical screening program with human papillomavirus vaccine'. Together they form a unique fingerprint.

Cite this